We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Neose Receives Notice of Allowance for U.S. Patent

Neose Receives Notice of Allowance for U.S. Patent

Neose Receives Notice of Allowance for U.S. Patent

Neose Receives Notice of Allowance for U.S. Patent

Read time:

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Neose Receives Notice of Allowance for U.S. Patent"

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Neose Technologies, Inc. has announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a pending patent application related to its GlycoPEGylation™ technology.

The allowed U.S. claims broadly cover glycosyl-linked poly (ethylene glycol) ("PEG") conjugates of therapeutic peptides.

This is the first allowed patent application in a series of pending patent applications directed toward the company's GlycoConjugation™ technology platform.

"We believe the Notice of Allowance for these claims validates the unique nature of our technology and gives us a proprietary advantage in our primary strategy of developing next-generation therapeutic peptides," said David A. Zopf, M.D., executive vice president and chief scientific officer of Neose.

"The applicability of this patent is extensive in that it validates the patentability in the United States of Neose's technology and next-generation peptide therapeutics produced using this technology, as well as providing guidance for Neose in securing patent protection outside the United States," continued Dr. Zopf.

The issuance of this patent will complement the company's broad intellectual property portfolio.

Neose owns 25 issued U.S. patents and has licensed 68 issued U.S. patents from other institutions.